Adamis Pharmaceuticals Corporation ADMP was a big mover last session, as the company saw its shares rise 8% on the day. The move came on solid volume too with far more shares changing hands than in a ...
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At ...
Adamis Pharmaceuticals (ADMP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
The shares of Adamis Pharmaceuticals Corp (NASDAQ:ADMP) have added 11.2% to trade at $2.92 in early market trading, on the U.S. launch of the company's allergy treatment, Symjepi. The drug -- launched ...
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) was on a downward slide for most of the past five years. However, for several months in 2020, and again early in 2021, it came to life. Last year, it peaked ...
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) shares gained more than 50% today following the approval of its pre-filled single dose syringe for the emergency treatment of allergic reactions. Last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results